BRAINSTORM CELL THERAPEUTICS INC (BCLI) is a publicly traded company in the Unknown sector. Across all available filings, 29 corporate insiders have executed 244 transactions totaling $4.0M, demonstrating a bullish sentiment with $65.3K in net insider flow. The most recent transaction on Jul 19, 2024 involved a sale of 63,000 shares valued at $22.1K.
No significant insider buying has been recorded for BCLI in the recent period.
No significant insider selling has been recorded for BCLI in the recent period.
Based on recent SEC filings, insider sentiment for BCLI is bullish with an Insider Alignment Score of 51/100 and a net flow of $65.3K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at BRAINSTORM CELL THERAPEUTICS INC (BCLI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 29 insiders are actively trading BCLI stock, having executed 244 transactions in the past 90 days. The most active insider is Corp. Accbt (Executive), who has made 15 transactions totaling $4.5M.
Get notified when executives and directors at BCLI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 19, 2024 | B. Dagher Ibrahim | Executive | Sale | 63,000 | $0.35 | $22.1K | |
| Jun 24, 2024 | Hartounian Hartoun | Executive | Award | 30,000 | $N/A | $0 | |
| May 28, 2024 | Lebovits Chaim | Executive | Purchase | 15,000 | $0.52 | $7.8K | |
| May 28, 2024 | Lebovits Chaim | Executive | Award | 15,000 | $0.52 | $7.8K | |
| May 22, 2024 | Lebovits Chaim | Executive | Purchase | 25,000 | $0.64 | $16.0K | |
| May 22, 2024 | Lebovits Chaim | Executive | Award | 25,000 | $0.64 | $16.0K | |
| May 21, 2024 | Lebovits Chaim | Executive | Purchase | 25,000 | $0.58 | $14.5K | |
| May 21, 2024 | Lebovits Chaim | Executive | Award | 25,000 | $0.58 | $14.5K | |
| May 13, 2024 | Lebovits Chaim | Executive | Purchase | 10,000 | $0.49 | $4.9K | |
| May 13, 2024 | Lebovits Chaim | Executive | Award | 10,000 | $0.49 | $4.9K | |
| May 11, 2024 | Lebovits Chaim | Executive | Purchase | 10,000 | $0.47 | $4.7K | |
| May 11, 2024 | Lebovits Chaim | Executive | Award | 10,000 | $0.47 | $4.7K | |
| May 10, 2024 | Lebovits Chaim | Executive | Purchase | 20,000 | $0.47 | $9.4K | |
| May 10, 2024 | Lebovits Chaim | Executive | Award | 20,000 | $0.47 | $9.4K | |
| May 7, 2024 | Lebovits Chaim | Executive | Purchase | 66,300 | $0.37 | $24.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Exercise(M) | 9 | $4.4M | 49.5% |
Purchase(P) | 79 | $2.1M | 23.2% |
Sale(S) | 53 | $2.0M | 22.5% |
Award(A) | 95 | $311.4K | 3.5% |
Payment(F) | 3 | $116.0K | 1.3% |
Gift(G) | 2 | $0 | 0.0% |
Disposition(D) | 1 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Exercise (Options)(X) | 1 | $0 | 0.0% |
Insider activity at BRAINSTORM CELL THERAPEUTICS INC shows mixed signals across all time. While $2.1M in purchases indicates some executive confidence,$2.0M in sales balances the picture, resulting in a modest net flow of $65.3K.29 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Corp. Accbt, has transacted $4.5M during this period.